Company page

Qiagen N.v.

Qiagen N.V. is a public company traded under the ticker QGEN in the American market. With a market capitalization of approximately $7.61 billion, Qiagen specializes in providing sample and assay technologies for molecular diagnostics and life sciences. The company focuses on advancing healthcare by enabling the extraction and analysis of DNA, RNA, and proteins from various samples.